ALS, the progressive and fatal neurodegenerative disorder leading to muscle atrophy, loss of movement, and eventually death, could gain benefits through inhibition of CDK5 [51, 56–58]. This evidence concerns the gene CDK5 and amyotrophic lateral sclerosis.